About vecuronium bromide
Nondepolarizing neuromuscular blocking agent
Used for
- Temporarily relaxes skeletal muscles during surgery.
- Helps enable mechanical ventilation in intensive care.
Usual adult dose
Given intravenously by an anesthetist; commonly 0.08–0.1 mg/kg initially, with smaller doses as needed.
Usual dose in children
Given intravenously by specialists; dosing varies by age and procedure, commonly 0.08–0.1 mg/kg initially.
Common side effects
- Prolonged muscle weakness or paralysis
- Breathing difficulty if ventilation is not supported
- Low blood pressure
- Allergic reactions
Important warnings
- Causes paralysis, including inability to breathe; ventilation and close monitoring are essential.
- Use only by trained clinicians with resuscitation equipment available.
- Does not cause unconsciousness or relieve pain; anesthesia and pain control are needed.
- Effects may be prolonged with certain illnesses or medicines.
Pregnancy
Use only when clearly needed; evidence is limited, and effects on the newborn are possible.
Breastfeeding
Information is limited; specialist advice is needed. Its poor absorption by mouth may make infant exposure low.
Interactions
- Some antibiotics and anesthetic medicines can intensify or prolong paralysis.
- Magnesium, lithium, and certain heart medicines may increase neuromuscular blockade.
- Medicines that reverse paralysis can alter its effects.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.